HCID 14365144, compound → HCID 14365147, compound
Reaction equation
[CH2:1]([C@@H:10]1[O:12][C@H:11]1[C:13]([OH:15])=[O:14])[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][CH3:9].[CH2:16]([S:24][C:25]1[N:30]=[CH:29][C:28]([C:31]2[CH:36]=[CH:35][C:34](O)=[CH:33][CH:32]=2)=[CH:27][N:26]=1)[CH2:17][CH2:18][CH2:19][CH2:20][CH2:21][CH2:22][CH3:23]>C(Cl)Cl.CN(C)C1C=CN=CC=1>[CH2:1]([C@@H:10]1[O:12][C@H:11]1[C:13]([O:15][C:34]1[CH:33]=[CH:32][C:31]([C:28]2[CH:27]=[N:26][C:25]([S:24][CH2:16][CH2:17][CH2:18][CH2:19][CH2:20][CH2:21][CH2:22][CH3:23])=[N:30][CH:29]=2)=[CH:36][CH:35]=1)=[O:14])[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][CH3:9]Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
A solution of 413 mg (2.0 mmol) of dicyclohexyldicarbodiimide in 10 ml of dry CH2Cl2 is added while stirring at room temperature to 429 mg (2 mmol) of (2R,3S)-3-nonyloxirane-2-carboxylic acid, 633 mg (2 mmol) of 4-(2-n-octylthiopyrimidin-5-yl) phenol and also 20 mg of 4-dimethylaminopyridine. After stirring for 4 hours at room temperature, the reaction solution is evaporated down in vacuo. After chromatographic purification and recrystallization from n-hexane, 120 mg (12%) of colorless crystals are obtained. The substance exhibits the liquid-crystal phase sequence: X 73 SA 93.5 I.
Workup
- customthe reaction solution is evaporated down in vacuo
- customAfter chromatographic purification and recrystallization from n-hexane, 120 mg (12%) of colorless crystals
- customare obtained
Sources & evidence
- ORD record
- ord-28f274633a334e8e97adeb40378e9357
- Source dataset
- uspto-grants-1991_01
- Patent number
- US04988459
Reaction notes
Loading…